Autoantibodies to Folate Receptors in the Cerebral Folate Deficiency Syndrome

  • Ramaekers V
  • Rothenberg S
  • Sequeira J
  • et al.
230Citations
Citations of this article
113Readers
Mendeley users who have this article in their library.

Abstract

In infantile-onset cerebral folate deficiency, 5-methyltetrahydrofolate (5MTHF) levels in the cerebrospinal fluid are low, but folate levels in the serum and erythrocytes are normal. We examined serum specimens from 28 children with cerebral folate deficiency, 5 of their mothers, 28 age-matched control subjects, and 41 patients with an unrelated neurologic disorder. Serum from 25 of the 28 patients and 0 of 28 control subjects contained high-affinity blocking autoantibodies against membrane-bound folate receptors that are present on the choroid plexus. Oral folinic acid normalized 5MTHF levels in the cerebrospinal fluid and led to clinical improvement. Cerebral folate deficiency is a disorder in which autoantibodies can prevent the transfer of folate from the plasma to the cerebrospinal fluid.

Cite

CITATION STYLE

APA

Ramaekers, V. T., Rothenberg, S. P., Sequeira, J. M., Opladen, T., Blau, N., Quadros, E. V., & Selhub, J. (2005). Autoantibodies to Folate Receptors in the Cerebral Folate Deficiency Syndrome. New England Journal of Medicine, 352(19), 1985–1991. https://doi.org/10.1056/nejmoa043160

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free